Document is current
Any future updates will be listed below
-
Authors
Li, Zhitong
Ren, Wenxia
Li, Xuhui
Duan, Ruixue
Gao, Linlin
Li, Jiaojiao
Bai, Yajing
Yan, Yuanyuan
Lü, Angxian
Zhao, Anqi
Liu, Shiwei
-
Funding
Funding for this research was provided by:
Shanxi Province Basic Research Program (202303021212330)
Collaborative Traditional Chinese and Modern Medicine for Chronic Disease Management Research Project (CXZH2024085)
hanxi Province Metabolic Disease (Type 1 Diabetes) Clinical Medical Research Center (20240410501001)
Shanxi Province Science and Technology Achievements Transformation Guidance Special Fund (202304021301066)
Shanxi Province Science and Technology Innovation Talent Team Special Plan (202204051002029)
Shanxi Province Research Funding for Returned Overseas Scholars (2024-143)
Shanxi Province Key Laboratory of Endocrine and Metabolic Diseases (202404010920011)
- License Information
-
More Information
Article History
Received: 18 August 2025
Accepted: 16 October 2025
First Online: 14 November 2025
Declarations
:
: Approval for this project was granted by the Biomedical Ethics Committee of Peking University (Beijing, China) (IRB00001052-11015), with our study adhering strictly to the principles outlined in the Declaration of Helsinki, and obtaining informed consent from all participants.
: Not applicable.
: The authors declare no competing interests.
